Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
10/06/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 5, 2024 in Altimmune, Inc. Lawsuit - ALT | NASDAQ:ALT | Altimmune Inc |
05/06/2024 | 13:00 | GlobeNewswire Inc. | Altimmune Presents Data at EASL International Liver Congress™ 2024 Supporting the Disease Modifying Potential and Differentiated Therapeutic Profile of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis (MASH) | NASDAQ:ALT | Altimmune Inc |
05/06/2024 | 11:45 | PR Newswire (US) | Altimmune, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - ALT | NASDAQ:ALT | Altimmune Inc |
29/05/2024 | 13:31 | GlobeNewswire Inc. | Altimmune to Participate at Two Upcoming Investor Conferences | NASDAQ:ALT | Altimmune Inc |
29/05/2024 | 13:30 | GlobeNewswire Inc. | Altimmune to Present Clinical Data from Pemvidutide at Upcoming EASL International Liver Congress™ 2024 | NASDAQ:ALT | Altimmune Inc |
29/05/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Notifies Shareholders of Altimmune, Inc.(ALT) of a Class Action Lawsuit and an Upcoming Deadline | NASDAQ:ALT | Altimmune Inc |
21/05/2024 | 15:00 | PR Newswire (US) | Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM) | NASDAQ:ALT | Altimmune Inc |
21/05/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Notifies Altimmune, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ALT | NASDAQ:ALT | Altimmune Inc |
14/05/2024 | 11:45 | PR Newswire (US) | Contact The Gross Law Firm by July 5, 2024 Deadline to Join Class Action Against Altimmune, Inc.(ALT) | NASDAQ:ALT | Altimmune Inc |
10/05/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Altimmune, Inc.(ALT) Shareholders | NASDAQ:ALT | Altimmune Inc |
09/05/2024 | 23:51 | PR Newswire (US) | INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Altimmune Inc. to Contact Law Firm | NASDAQ:ALT | Altimmune Inc |
09/05/2024 | 22:05 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ALT | Altimmune Inc |
09/05/2024 | 13:04 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ALT | Altimmune Inc |
09/05/2024 | 13:00 | GlobeNewswire Inc. | Altimmune Announces First Quarter 2024 Financial Results and Provides a Business Update | NASDAQ:ALT | Altimmune Inc |
02/05/2024 | 13:30 | GlobeNewswire Inc. | Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024 | NASDAQ:ALT | Altimmune Inc |
01/05/2024 | 13:30 | GlobeNewswire Inc. | Altimmune to Participate at Two Upcoming Conferences | NASDAQ:ALT | Altimmune Inc |
25/04/2024 | 23:24 | GlobeNewswire Inc. | Altimmune Statement on the Passing of Dr. Stephen Harrison | NASDAQ:ALT | Altimmune Inc |
27/03/2024 | 12:00 | GlobeNewswire Inc. | Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results | NASDAQ:ALT | Altimmune Inc |
27/03/2024 | 11:57 | IH Market News | U.S. Stock Index Futures Point to a Rebound, Oil See Declines in Early Trading | NASDAQ:ALT | Altimmune Inc |
20/03/2024 | 12:30 | GlobeNewswire Inc. | Altimmune to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 27, 2024 | NASDAQ:ALT | Altimmune Inc |
14/02/2024 | 18:04 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:ALT | Altimmune Inc |
06/02/2024 | 00:02 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALT | Altimmune Inc |
26/01/2024 | 17:49 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:ALT | Altimmune Inc |
02/01/2024 | 13:30 | GlobeNewswire Inc. | Altimmune Announces Presentation of Pemvidutide Clinical Data at Upcoming NASH-TAG Conference on January 6, 2024 | NASDAQ:ALT | Altimmune Inc |
08/12/2023 | 14:35 | GlobeNewswire Inc. | Water Tower Research US Climate Virtual Investor Conference: Presentations Now Available for Online Viewing | NASDAQ:ALT | Altimmune Inc |
04/12/2023 | 14:35 | GlobeNewswire Inc. | Water Tower Research US Climate Investor Conference Agenda Announced for December 7th, 2023 | NASDAQ:ALT | Altimmune Inc |
30/11/2023 | 22:24 | GlobeNewswire Inc. | Altimmune Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity Trial of Pemvidutide | NASDAQ:ALT | Altimmune Inc |
07/11/2023 | 13:00 | GlobeNewswire Inc. | Altimmune Announces Third Quarter 2023 Financial Results and Provides a Business Update | NASDAQ:ALT | Altimmune Inc |
31/10/2023 | 12:30 | GlobeNewswire Inc. | Altimmune to Report Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023 | NASDAQ:ALT | Altimmune Inc |
26/10/2023 | 14:15 | Dow Jones News | Altimmune Gets FDA Fast-Track Designation for Pemvidutide in NASH | NASDAQ:ALT | Altimmune Inc |